Author:
Halenka Milan,Fryšák Zdeněk
Publisher
Springer International Publishing
Reference9 articles.
1. Guo K, Wang Z. Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis. Int J Clin Exp Pathol. 2014;7(9):5393–403.
2. Durante C, Montesano T, Torlontano M, Attard M, Monzani F, Tumino S, et al. PTC Study Group. Papillary thyroid cancer: time course of recurrences during postsurgery surveillance J Clin Endocrinol Metab. 2013; 98(2): 636–642.
3. Napolitano G, Romeo A, Vallone G, Rossi M, Cagini L, Antinolfi G, et al. How the preoperative ultrasound examination and BFI of the cervical lymph nodes modify the therapeutic treatment in patients with papillary thyroid cancer. BMC Surg. 2013;13 Suppl 2:S52.
4. Mazzaferri EL, Jhiang SM. Differentiated thyroid cancer long-term impact of initial therapy. Trans Am Clin Climatol Assoc. 1995;106:151–70.
5. Torlontano M, Attard M, Crocetti U, Tumino S, Bruno R, Costante G, et al. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab. 2004;89(7):3402–7.